Omega Protein Co (NYSE:OME) Investors: D. A. Davidson Keeps Neutral Rating, Sees $26.00/Share

Share with your friends


Davidson Analyst Rating Change Omega Protein Co NYSE:OME

Omega Protein Co (NYSE:OME) Rating Reconfirmed

D. A. Davidson have a $26.00 target price per share on the stock. The target price per share indicates a potential upside of 6.12 % from Omega Protein Co (NYSE:OME)’s previous close. This rating was disclosed to clients in a note on Thursday, 4 August.

NYSE:OME is currently trading 5.11% higher at $24.50 as of 10:27 New York time. Omega Protein Co’s stock is up 27.73% over the past 200 days. It has outperformed the S&P500 Index, which has surged 6.43% over the same time.

According to data compiled by Thomson Reuters, Omega Protein Co (NYSE:OME)’s stock is covered by 3 equity analysts across the Street, with 0 analysts giving it a Sell rating, 2 a Buy rating, while 2 consider it a Hold. The 12-month consensus target price for the stock is $21.67, which reflects an downside potential of 11.55% over the current price.

NYSE:OME Price Chart & Trend

The stock price of Omega Protein Co has skyrocketed 27.73% over the last 200 days, and is in very strong up trend. In the last 50 and 100 days, Omega Protein Co is up 24.59% and up 23.99%, respectively. Our stocks momentum model is shown on the price chart below.Omega Protein Co (NYSE:OME) Investors: D. A. Davidson Keeps Neutral Rating, Sees $26.00/Share

Source: RightEdge Systems, Yahoo Split & Dividend Adjusted Data and OctaFinance Trading Models

Institutional Ownership

Wynnefield Capital Inc had the largest stake with ownership of 1.38 million shares as of q2 2015 for 7.32% of the US equity exposure. Tinicum Inc is another bull as the institutional investor who is possessing 610,800 shares of Omega Protein Co or 4.19% of their US equity exposure. Also, Bruce & Co. Inc. have 1.21% of their US equity exposure invested in the company for 341,000 shares. The New York-based fund Gerstein Fisher revealed it had bought a stake worth about 0.79% of the institutional investor’s stock portfolio in Omega Protein Co. The Connecticut-based fund Thomson Horstmann & Bryant Inc is also positive about the stock, possessing 168,066 shares or 0.6% of their US equity exposure.

Omega Protein Co (NYSE:OME) Profile

Omega Protein Corporation is a nutritional products company that develops, produces and delivers nutritious products across the world. The Company operates through two segments: animal nutrition and human nutrition. The Company’s animal nutrition segment consists primarily of two subsidiaries: Omega Protein, Inc. (Omega Protein) and Omega Shipyard, Inc. (Omega Shipyard).

Omega Protein Co (NYSE:OME) traded up 5.11% on 4 August, hitting $24.5. A total of 770,856 shares of the company’s stock traded hands. This is up from average of 152,837 shares. Omega Protein Co has a 52 week low of $14.29 and a 52 week high of $25.65. The company has a market cap of $560.34 million and a P/E ratio of 17.91.

Get the latest Omega Protein Co (NYSE:OME) Stock Ratings at Octafinance. Completely free access to our Analyst Ratings Database for 6000+ stocks.

#metarobot=’index’##metadesc=’ Omega Protein Co (NYSE:OME) Rating Reiterated’##focuskw=’Omega Protein Co (NYSE:OME)’##newskw=’Omega Protein Co (NYSE:OME),D. A. Davidson Analyst Rating Change, OME Stock Rating,NYSE:OME Rating Reiterate,Omega Protein Co (NYSE:OME) target price,Omega Protein Co (NYSE:OME) D. A. Davidson report,NYSE:OME stock news,OME stock risks upside,D. A. Davidson equity research coverage’##sitemap=’include’##skipsocial##stockticker=’NYSE:OME’#

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.